Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label pilot phase 1/2 study of inhaled medical cannabis via the Syqe inhaler for chronic insomnia
MOH_2020-07-20_009116Phase 2Not yet recruiting
- Sponsor
- דר איתי גור-אריה
- Start
- May 2019
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of medical cannabis in Insomnia, sponsored by דר איתי גור-אריה. Primary endpoints: Optimal THC dose identification and Effect of optimal dose over 3 months. Planned start May 2019; status: not yet recruiting.
02
Drugs
medical cannabis
03
Conditions
Insomnia
Beyond the preview
Go deeper on MOH_2020-07-20_009116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-07-20_009116.